The ASAN Easy Test H. pylori is a newly developed rapid test for Helicobacter pylori that uses a stool antigen immunochromatographic assay (S-ICT). The aim of this study was to evaluate this kit for the diagnosis of H. pylori under various histological conditions. We enrolled 266 consecutive patients undergoing a routine health checkup and endoscopy with biopsy. H. pylori infection was confirmed if at least 2 out of the 3 following tests were positive: histology, real-time polymerase chain reaction (PCR), and the stool antigen test by enzyme immunoassay (S-EIA). Histological examination was performed using hematoxylin-eosin and silver staining. Real-time PCR was performed with a probe for the UreA gene as described previously. The S-EIA and the evaluated kit were used according to the manufacturers' instructions. Of the 266 patients, 209 were eligible for participation. The evaluation results were as follows: sensitivity, 84.5z; specificity, 96.2z; positive-predictive value, 95.6z; negative-predictive value, 86.4z; and accuracy, 90.4z. The performance of the kit was unaffected by histological findings such as atrophic gastritis, ulcers, and intestinal metaplasia. The newly developed S-ICT assay is a non-invasive rapid test for the diagnosis of H. pylori that exhibits good performance in routine health checkup patients.
Helicobacter pylori is a microaerophilic, Gram-negative flagellate, spiral-shaped bacterium that colonizes the antral region of the human stomach (1) . Although its prevalence varies both among countries and within the population group of a country, its overall prevalence in middle-aged adults exceeds 80z in many developing countries and is 20-50z in industrialized countries (2) . H. pylori infection is associated with gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric cancer (2) . There are several invasive and non-invasive methods for diagnosing H. pylori infection. Invasive diagnostic methods include culture, histology, and the rapid urease test. Meanwhile, non-invasive diagnostic methods include the urea breath test, serological test, stool antigen test by enzyme immunoassay (S-EIA), and stool antigen test by immunochromatography (S-ICT). Non-invasive diagnostic methods are regarded as global tests because they cover more than 0.5 m 2 gastric mucosa (3) . Previous studies have reported wide variations in the sensitivity and specificity of the stool antigen test, which were likely due to variations in the clonality of the antibody, differing prevalences of H. pylori infection before and after eradication treatment, and differing definitions of standard methods. The sensitivity and specificity of the S-EIA before eradication treatment were reported to range 85-100z and 66.6-97.8z, respectively (4) (5) (6) (7) (8) (9) . On the other hand, the sensitivity and specificity of the S-ICT, a rapid immunoassay, range 52.5-95.0z and 55.5-96.0z, respectively (4-10).
Polyclonal or monoclonal antibodies to proteins such as H. pylori catalase have been used to detect H. pylori (10, 11) . In recent reports, the sensitivity and specificity ranges of diagnostic tests using monoclonal and polyclonal antibodies were as follows: sensitivity for monoclonal antibodies, 91.9-93.8z; specificity, 70.7-100z; sensitivity for polyclonal antibodies, 81.3-89.4z; specificity, 80.5-97.5z (12) (13) (14) (15) . Overall, the performance of monoclonal antibodies was better than that of polyclonal antibodies.
Among different geographical regions, the prevalence of H. pylori in Asia ranged 15.5-94.3z (2, 16 ). Since the prevalence of H. pylori is still high, feasible diagnostic kits are required for the determination of diagnosis and follow-up after eradication treatment. The S-ICT method is a non-invasive rapid immunoassay with a turnaround time of less than 15 min. It is cost effective, additional instruments are not required, and can be utilized in primary care clinics as well as in the central laboratory of hospitals. Considering this background, a diagnostic kit using the S-ICT method was developed. Therefore, we evaluated the efficacy of the ASAN Easy Test H. pylori, a newly developed H. pylori diagnostic kit using the S-ICT method that uses monoclonal antibodies against flagellin, and assessed the diagnostic performance of this test in various histological and demographic conditions.
We enrolled 266 consecutive patients undergoing a routine health checkup and receiving endoscopy and biopsy between December 2010 and March 2011 in this study. Patients with a history of antibiotics, proton pump inhibitors, bismuth within 1 month, previous gastric surgery, and previous diagnosis of gastric cancer were excluded. Stool specimens were collected and stored at -209 C upon arrival at the laboratory after DNA extraction was performed. The stool was thawed for S-EIA and S-ICT, and subsequently stored again at -209 C for future retesting. The Institutional Review Board of the hospital approved this study. The ASAN Easy Test H. pylori (ASAN Pharmaceutical, Seoul, Korea) was used according to the manufacturer's instructions. The assay was based on S-ICT, using a single monoclonal antibody agasint H. pylori flagellin antigens. In brief, a plastic bar was used to add 500 mg to 1 g fecal sample to a vial containing 1 mL buffer. After gentle vortexing, the fecal sample was emulsified. Two to four drops of emulsified stool sample were placed in the sample port of the test cassette. The test was interpreted after 15 min at room temperature. The appearance of a red line in the reading window indicated a positive result, with the positive control band that was also red in color. The test results were interpreted by 2 of the authors of this study.
The endoscopy and biopsy results from the subjects' medical records were investigated. Biopsy specimens were prepared for histological examination by staining with hematoxylin-eosin and Warthin-Starry silver stains; diagnoses were made using the Sydney classification (17) . At least one biopsy specimen had been obtained from the antrum, with additional specimens obtained from other sites. The number of biopsy specimens was as follows: 1 specimen, 143 cases; 2 specimens, 49 cases; and 3 or more specimens, 17 cases. The grade of H. pylori presence was recorded as follows: mild, few focal areas of bacteria; moderate, bacteria in several areas; and severe, abundant bacteria in most glands. The presence of atrophic gastritis, intestinal metaplasia, lymphoid aggregates and/or follicles, gastric ulcers, and ulcer scars was also recorded.
The S-EIA, which uses a coated polyclonal antibody in microwells, was performed as described previously (5) . In brief, diluted fecal samples and peroxidase-conjugated polyclonal antibodies were added to microwells. After 1-h incubation at room temperature, the microwells were washed and the presence of H. pylori antigens was determined by the absence of yellow, which was detected at 450/620 nm by a spectrophotometer. The overall sensitivity and specificity were 93.1z and 94.6z, respectively (5).
Real-time polymerase chain reaction (PCR) was performed as described previously with some modifications (18) . DNA was extracted from the stool specimen before freezing using a QIAamp DNA Stool Kit (Qiagen, Valencia, Calif., USA) according to the manufacturer's instructions. Meanwhile, H. pylori DNA for the control was extracted using a QIAamp DNA Mini Kit. The primers and probe for the UreA gene were as follows: ureA-F, 5?-CGTGGCAAGCATGATCCAT-3?; ureA-R, 5?-GGGTATGCACGGTTACGAGTTT-3?; and ureA-Probe, 5?-Fam-TCAGGAAACATCGCTTCAA TA-CCCACTT-Tamra-3?. Real-time PCR reactions were performed with an Exicycler (Bioneer Corp., Daejeon, Korea) (19) . For UreA gene detection (77 base pair), the reaction mixture contained 4 mM MgCl 2 , 1 mL forward primer (10 pmol), 1 mL reverse primer (10 pmol), 2 mL probe (20 pmol), 100 ng stool DNA, and PCR-grade water to a final volume of 20 mL. The PCR conditions were as follows: 1 cycle of 959 C for 10 min; 45 cycles of 959 C for 30 s, 609 C for primer for 30 s, 729 C for 30 s; and 1 cycle of 409 C for 1 min. The test was performed in duplicate; an additional test was performed for cases that exhibited discordance. Cases were considered as positive or negative based on the results of 2 of the 3 tests exhibiting concordance. The efficiency of the assays was determined by standard curves based on 10-fold serial dilutions of H. pylori. The overall sensitivity and specificity were 98.0z and 98.0z, respectively (18) .
The diagnosis of H. pylori infection was established by the concordance of 2 or more positive test results from the 3 tests performed (i.e., histology, real-time PCR, and S-EIA). H. pylori infection status was classified as follows, with some modifications (12, 20) : definite positive, all 3 tests show positive results, or a positive histology result and either of the other tests shows a positive result; probable positive, positive results by real-time PCR and S-EIA; and negative, all 3 tests are negative. Fifty-seven patients with only 1 positive result among the 3 tests were regarded to have falsepositive results and were excluded from analysis (12) . All statistical analyses were performed using the R program. The Z test was used to compare proportions between groups.
Among the 266 enrolled patients, 209 patients (124 men and 85 women) were included in the analysis. The prevalence of H. pylori infection in males and females was 37.9z and 29.4z, respectively. The median age of the patients was 51 years (range, 26-85 years). The prevalence of H. pylori infection in patients º40 and AE40 years was 33.3z and 35.2z; º50 and AE50 years, 41.2z and 30.6z; and º60 and AE60 years, 36.5z and 30.1z, respectively. There were no significant differences between each pair of age groups.
The endoscopic results with respect to the esophagus revealed gastroesophageal reflux disease (GERD), reflux esophagitis, and Barrett's esophagus in 45 (21.5z), 25 (11.9z), and 14 (6.7z) patients, respectively. The prevalence of H. pylori infection with and without GERD was 37.8z and 52.4z, respectively; the difference was not significant ( P ＝ 0.074, Z test).
The endoscopic results with respect to the gastric mucosa were as follows: normal, 27 (12.9z) 
Group A, definite positive; Group B, probable positive; Group C, negative. PCR, polyermase chain reaction; S-EIA, stool antigen by enzyme immunoassay. with ulcers in the presence or absence of an ulcer scar using endoscopy was high, with a sensitivity of 90.5z and specificity of 100z. The diagnostic performance of the test for detecting patients with or without GERD exhibited similar sensitivity and specificity. In the presence of intestinal metaplasia, lymphoid aggregates and/or follicles, and chronic active gastritis, the evaluated kit exhibited a similar diagnostic performance, indicating that the effect of histological differences on diagnosis was limited. The diagnostic performance in patients AE60 years had 75.0z sensitivity and 96.6z specificity. The stool antigen test for H. pylori diagnosis has been approved by the US Food and Drug Administration for use in primary diagnosis and monitoring after treatment. In addition, the Maastricht III Consensus report recommends the use of both the urea breath test and stool antigen test for the diagnosis and follow-up of H. pylori infection (7, 21) . The stool antigen test by monoclonal antibodies and urea breath test are reported to be roughly equivalent in the diagnostic screening of untreated patients. However, the urea breath test is preferred for follow-up (3).
The S-ICT is non-invasive, cost effective, and requires less than 15 min to perform. Therefore, it is convenient for patients and can be easily performed even in small laboratories and primary outpatient clinics. On the other hand, the S-EIA requires detection equipment such as a spectrophotometer; the test is also performed in batches, which delays the diagnostic process (4).
The prevalences of H. pylori infection by disease in previous studies and in the present study are as follows: reflux esophagitis, 6.6z versus 11.9z; peptic ulcer, 5.6-56.7z versus 16.6z; intestinal metaplasia, 23.1z versus 12.4z; atrophic gastritis, 7.0z versus 20.1z, respectively (22) (23) (24) . Despite the size of the studied population, diagnostic method, and differing geographic region, the prevalence of H. pylori infection in the present study is similar to that in previous reports.
The sensitivity and specificity of the evaluated kit are slightly lower than that of a systematic view of 89 studies, which determined sensitivities of 91z and 93z (7) . Although it is recommended to test multiple stool specimens in batches (21) , only one sample was used for each patient in this study, which may have decreased the sensitivity by 5-10z.
The rates of positive histological diagnoses of H. pylori infection by the number of specimens were as follows: 1 specimen, 31.5z (45/143); 2 specimens, 44.9z (22/49); and 3 or more specimens, 29.4z (5/17). Although the infection rate was high when 2 specimens were obtained, it was not significantly higher than that determined with 1, or 3 or more specimens. A previous study reported that people Ã40 years of age showed higher positive rates of H. pylori infection (5). However, there were no significant differences between age groups in the present study. The overall prevalence was approximately 30-40z.
The use of monoclonal or polyclonal antibodies to detect H. pylori in the S-EIA test was associated with test performance. The S-EIA test using monoclonal antibodies had 91.6-93.8z sensitivity and 70.7-100z specificity; with polyclonal antibodies, sensitivity was 81.3-89.4z and specificity 80.5-97.5z (10) (11) (12) (13) (14) . Previous studies reported that tests using monoclonal antibodies performed better than tests with polyclonal antibodies. In the present study, the ASAN Easy Test H. pylori, a diagnostic kit using the S-ICT method showed 84.5z sensitivity and 96.2z specificity, which were lower and higher, respectively, than that of a previous report (12) . Different antibody targets may explain these discrepancies (antibodies against H. pylori flagellin were used in the present study), as may the prevalence of infection rates and different pathologic conditions, such as patients with ulcers who showed better test performance than patients without ulcers did.
The results indicated that the performance of the evaluated kit was robust, regardless of the histological findings. Unlike the rapid urease test, which has been reported to have low sensitivity in atrophic gastritis and intestinal metaplasia (19, 25) , the present study showed 81-100z sensitivity and specificity in cases of atrophic gastritis, intestinal metaplasia, chronic active gastritis, and intestinal metaplasia. GERD has been reported to be inversely correlated with H. pylori infection rates (25) . In the present study, the prevalence of H. pylori infection showed an inverse correlation between these 2 groups, but the performance of the evaluated kit produced similar results.
Unexpectedly, the performance of the evaluated kit among patients with ulcers showed 90.5z sensitivity and 100z specificity, which may have been due to a greater H. pylori burden. The inclusion of patients with ulcers may have affected the diagnostic performance of the test in the present and previous studies. Therefore, guidelines for establishing the ratio of patients with and without ulcers to be included in evaluations of stool antigen tests may be required to reduce selection bias.
A limitation of this study is that it only investigated the performance of the test during initial diagnosis of H. pylori infection and not at follow-up (3). In addition, pediatric patients were omitted from the present study. Another limitation is that there is no reference method for the diagnosis of H. pylori infection. Combinations of at least 2 tests have been adopted (26) , including histology, S-EIA, and real-time PCR using a probe for the urease gene. The tests used in the present study are different from those used in previous studies, including the urea breath test, culture, rapid urease test on biopsy specimens, serological testing, and histology as the gold standard.
The newly developed stool antigen test using an immunochromatographic assay is a non-invasive rapid test for H. pylori diagnosis that demonstrates high performance among routine health checkup patients.
